233 related articles for article (PubMed ID: 11712744)
1. Anti-leukotrienes for asthma.
Calhoun WJ
Curr Opin Pharmacol; 2001 Jun; 1(3):230-4. PubMed ID: 11712744
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
Bisgaard H
Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
[TBL] [Abstract][Full Text] [Related]
3. Leukotrienes, antileukotrienes and asthma.
Montuschi P
Mini Rev Med Chem; 2008 Jun; 8(7):647-56. PubMed ID: 18537720
[TBL] [Abstract][Full Text] [Related]
4. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.
Devillier P; Baccard N; Advenier C
Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985
[TBL] [Abstract][Full Text] [Related]
5. Leukotriene synthesis inhibitors versus antagonists: the pros and cons.
Steinke JW; Culp JA
Curr Allergy Asthma Rep; 2007 May; 7(2):126-33. PubMed ID: 17437683
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study on bronchial asthma and leukotriene antagonists].
Yokoyama A
Nihon Naika Gakkai Zasshi; 2004 Dec; 93(12):2656-61. PubMed ID: 15658499
[No Abstract] [Full Text] [Related]
7. [Leukotriene modifiers in the treatment of asthma].
Alvarez J
Rev Alerg Mex; 1999; 46(3):72-7. PubMed ID: 10425884
[TBL] [Abstract][Full Text] [Related]
8. Cysteinyl leukotrienes in asthma: old mediators up to new tricks.
Hay DW; Torphy TJ; Undem BJ
Trends Pharmacol Sci; 1995 Sep; 16(9):304-9. PubMed ID: 7482995
[TBL] [Abstract][Full Text] [Related]
9. Genetics and pharmacogenetics of the leukotriene pathway.
Tantisira KG; Drazen JM
J Allergy Clin Immunol; 2009 Sep; 124(3):422-7. PubMed ID: 19665766
[TBL] [Abstract][Full Text] [Related]
10. Role of leukotrienes and leukotriene receptor antagonists in asthma.
Jones TR; Rodger IW
Pulm Pharmacol Ther; 1999; 12(2):107-10. PubMed ID: 10373391
[No Abstract] [Full Text] [Related]
11. [Antileukotriene drugs: a new treatment for asthma].
Armetti L; Nicosia S
Boll Chim Farm; 1999 Dec; 138(11):599-605. PubMed ID: 10765473
[TBL] [Abstract][Full Text] [Related]
12. Leukotriene modifiers in pediatric asthma management.
Bisgaard H
Pediatrics; 2001 Feb; 107(2):381-90. PubMed ID: 11158473
[TBL] [Abstract][Full Text] [Related]
13. Cysteinyl leukotriene interactions with other mediators and with glucocorticosteroids during airway inflammation.
Peters-Golden M; Sampson AP
J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S37-42; discussion S43-8. PubMed ID: 12532085
[TBL] [Abstract][Full Text] [Related]
14. Leukotriene modifiers for asthma treatment.
Montuschi P; Peters-Golden ML
Clin Exp Allergy; 2010 Dec; 40(12):1732-41. PubMed ID: 21059119
[TBL] [Abstract][Full Text] [Related]
15. Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs.
Claesson HE; Dahlén SE
J Intern Med; 1999 Mar; 245(3):205-27. PubMed ID: 10205583
[TBL] [Abstract][Full Text] [Related]
16. Treatment of asthma with drugs modifying the leukotriene pathway.
Drazen JM; Israel E; O'Byrne PM
N Engl J Med; 1999 Jan; 340(3):197-206. PubMed ID: 9895400
[No Abstract] [Full Text] [Related]
17. Antileukotriene treatment in children with asthma--new patents.
Stelmach I; Grzelewski T
Recent Pat Inflamm Allergy Drug Discov; 2008 Nov; 2(3):202-11. PubMed ID: 19076010
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene modifiers as novel therapeutics in asthma.
Leff JA
Clin Exp Allergy; 1998 Nov; 28 Suppl 5():147-53; discussion 171-3. PubMed ID: 9988461
[TBL] [Abstract][Full Text] [Related]
19. [May the Force be with antileukotriene drugs].
Szczeklik A
Pneumonol Alergol Pol; 2010; 78(1):1-2. PubMed ID: 20162512
[No Abstract] [Full Text] [Related]
20. Antileukotrienes in clinical development for asthma.
Centanni S; Santus P
Expert Opin Investig Drugs; 2002 Jan; 11(1):49-58. PubMed ID: 11772320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
